Syncom Formulations (India) Ltd's Stock Surges 8.34%, Reaches New 52-Week and All-Time High

Sep 09 2024 10:35 AM IST
share
Share Via
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has seen a surge in its stock price, reaching a new 52-week and all-time high of Rs. 24.95 on September 9th. The stock has gained 24.34% in the past four days and has outperformed the sector by 7.41%. Its strong performance and consistent trend make it a promising investment in the pharmaceutical industry.

Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been making headlines in the stock market with its recent surge in stock price. On September 9th, the company's stock gained 8.34%, closing at Rs. 24.95, which is also its new 52-week and all-time high. This positive performance has caught the attention of investors and market experts, with MarketsMOJO giving a 'Buy' call for the stock.

The stock has been on a winning streak for the past four days, with a consecutive gain of 24.34% during this period. It has also outperformed the sector by 7.41% today, showcasing its strong potential in the pharmaceutical and drugs industry. The stock's intraday high of Rs. 24.95 and low of Rs. 21.66 also indicate its high volatility, with a calculated intraday volatility of 7.27%.

Syncom Formulations (India) Ltd's performance has been consistently higher than the 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, further solidifying its positive trend in the market. In comparison to the Sensex, the stock has outperformed with a 1-day performance of 9.20% and a 1-month performance of 63.35%, while the Sensex has shown a -0.05% and 1.80% performance, respectively.

With its recent surge in stock price and strong performance, Syncom Formulations (India) Ltd is definitely a company to watch out for in the smallcap pharmaceutical industry. Investors can consider adding this stock to their portfolio for potential growth and returns.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Syncom Formul. falling/rising?
Nov 25 2025 01:16 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 19 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 17 2025 08:10 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 16 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 15 2025 08:10 AM IST
share
Share Via